CY1343A - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- CY1343A CY1343A CY1343A CY134380A CY1343A CY 1343 A CY1343 A CY 1343A CY 1343 A CY1343 A CY 1343A CY 134380 A CY134380 A CY 134380A CY 1343 A CY1343 A CY 1343A
- Authority
- CY
- Cyprus
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7910558 | 1979-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1343A true CY1343A (en) | 1987-01-16 |
Family
ID=10504143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1343A CY1343A (en) | 1979-03-27 | 1980-03-25 | Therapeutic agents |
Country Status (10)
Country | Link |
---|---|
JP (2) | JPS55130960A (es) |
BE (1) | BE882443A (es) |
CY (1) | CY1343A (es) |
ES (1) | ES489929A0 (es) |
GB (1) | GB2047691B (es) |
GE (1) | GEP19970835B (es) |
JO (1) | JO1072B1 (es) |
MX (1) | MX5950A (es) |
SU (1) | SU1124886A3 (es) |
ZA (1) | ZA801575B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA801575B (en) * | 1979-03-27 | 1981-03-25 | Boots Co Ltd | Therapeutic agents |
IE51542B1 (en) * | 1980-09-26 | 1987-01-07 | Boots Co Ltd | Therapeutic agents |
DE68917024D1 (de) * | 1988-05-24 | 1994-09-01 | Kirin Brewery | 4(1H)-Chinolonderivate. |
US8697674B2 (en) | 2004-12-29 | 2014-04-15 | Naturon, Inc. | Xanthurenic acid derivative pharmaceutical compositions and methods related thereto |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA801575B (en) * | 1979-03-27 | 1981-03-25 | Boots Co Ltd | Therapeutic agents |
-
1980
- 1980-03-18 ZA ZA00801575A patent/ZA801575B/xx unknown
- 1980-03-25 GB GB8010075A patent/GB2047691B/en not_active Expired
- 1980-03-25 CY CY1343A patent/CY1343A/xx unknown
- 1980-03-26 BE BE0/199956A patent/BE882443A/fr not_active IP Right Cessation
- 1980-03-26 ES ES489929A patent/ES489929A0/es active Granted
- 1980-03-26 JO JO19801072A patent/JO1072B1/en active
- 1980-03-27 JP JP3961080A patent/JPS55130960A/ja active Granted
-
1981
- 1981-01-19 SU SU802897803A patent/SU1124886A3/ru active
-
1985
- 1985-01-09 MX MX595085A patent/MX5950A/es unknown
-
1986
- 1986-12-24 JP JP61316048A patent/JPS62215526A/ja active Granted
-
1994
- 1994-09-07 GE GEAP19942162A patent/GEP19970835B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GEP19970835B (en) | 1997-02-10 |
GB2047691B (en) | 1983-07-20 |
ZA801575B (en) | 1981-03-25 |
ES8104232A1 (es) | 1981-04-16 |
JPH0250086B2 (es) | 1990-11-01 |
GB2047691A (en) | 1980-12-03 |
BE882443A (fr) | 1980-09-26 |
JPS62215526A (ja) | 1987-09-22 |
JPS55130960A (en) | 1980-10-11 |
JPH0114224B2 (es) | 1989-03-10 |
SU1124886A3 (ru) | 1984-11-15 |
ES489929A0 (es) | 1981-04-16 |
MX5950A (es) | 1993-11-01 |
JO1072B1 (en) | 1982-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA801328B (en) | Therapeutic agents | |
GB2000136B (en) | Therapeutic agents | |
GB2005248B (en) | Therapeutic agents | |
ZA782816B (en) | Therapeutic agents | |
ZA80298B (en) | Therapeutic agents | |
GB2000138B (en) | Therapeutic agents | |
ZA796708B (en) | Therapeutic agents | |
GB2000131B (en) | Therapeutic agents | |
EG16606A (en) | Therapeutic agents | |
ZA792390B (en) | Therapeutic agents | |
GB2013181B (en) | Therapeutic agents | |
GB2004876B (en) | Therapeutic agents | |
GB2007656B (en) | Therapeutic agents | |
GB2019836B (en) | Therapeutic agents | |
GB2053910B (en) | Pyridylaminotriazole therapeutic agents | |
GB2047691B (en) | Therapeutic agents | |
GB2000510B (en) | Therapeutic agents | |
GB2011890B (en) | Therapeutic agents | |
GB2010824B (en) | Therapeutic agents | |
GB2013179B (en) | Therapeutic agents | |
GB2011891B (en) | Therapeutic agents | |
GB2008104B (en) | Therapeutic agents | |
GB2007654B (en) | Therapeutic agents | |
ZA803988B (en) | Novel therapeutic combinations | |
GB2009156B (en) | Therapeutic agents |